The Manufacturers Life Insurance Company Acquires 4,305 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

The Manufacturers Life Insurance Company increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 543,401 shares of the company’s stock after buying an additional 4,305 shares during the period. The Manufacturers Life Insurance Company owned about 1.09% of Prestige Consumer Healthcare worth $37,413,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in PBH. Norges Bank bought a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth $27,739,000. UBS Group AG increased its stake in shares of Prestige Consumer Healthcare by 377.6% in the fourth quarter. UBS Group AG now owns 131,382 shares of the company’s stock valued at $8,043,000 after buying an additional 103,872 shares during the period. Franklin Resources Inc. raised its position in shares of Prestige Consumer Healthcare by 9.6% during the fourth quarter. Franklin Resources Inc. now owns 20,057 shares of the company’s stock worth $1,228,000 after acquiring an additional 1,764 shares during the last quarter. Hsbc Holdings PLC lifted its stake in shares of Prestige Consumer Healthcare by 8.9% in the fourth quarter. Hsbc Holdings PLC now owns 24,050 shares of the company’s stock worth $1,469,000 after acquiring an additional 1,975 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 42.5% in the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock valued at $44,000 after acquiring an additional 213 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on PBH shares. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.20.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock opened at $71.32 on Monday. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a 52 week low of $56.34 and a 52 week high of $75.80. The firm has a 50 day moving average of $71.21 and a 200-day moving average of $69.60. The company has a market cap of $3.53 billion, a price-to-earnings ratio of 17.10, a price-to-earnings-growth ratio of 2.01 and a beta of 0.48.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.04. The firm had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business’s revenue was down 4.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.06 earnings per share. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.